GNMLF Stock Genomma Lab International SAB DE CV (GNMLF, $0.96) was a top loser this quarter, falling -18.14%

GET DAILY SIGNALS

Get AI intraday signals

GNMLF - Genomma Lab International SAB DE CV

Loading...

Price: $0.9578

Daily change: +$0.0078 (+0.82%)

Daily volume: 13K

3-month price change: -$0.2122 (-18.14%)

Capitalization: $935.3M

Industry: Pharmaceuticals: Generic

Genomma Lab International SAB DE CV (GNMLF, $0.96) was a top loser over the last three months, falling -1 to $0.96 per share. A.I.dvisor analyzed 216 stocks in the Pharmaceuticals: Generic Industry for the 3-month period ending November 17, 2025, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend.

GNMLF in downward trend: price dove below 50-day moving average on February 02, 2026

GNMLF moved below its 50-day moving average on February 02, 2026 date and that indicates a change from an upward trend to a downward trend. In of 17 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GNMLF as a result. In of 37 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GNMLF turned negative on January 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 23 similar instances when the indicator turned negative. In of the 23 cases the stock turned lower in the days that followed. This puts the odds of success at .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

GNMLF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 93 cases where GNMLF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.540) is normal, around the industry mean (29.792). P/E Ratio (10.586) is within average values for comparable stocks, (74.095). Projected Growth (PEG Ratio) (0.463) is also within normal values, averaging (2.035). Dividend Yield (0.043) settles around the average of (0.029) among similar stocks. P/S Ratio (0.974) is also within normal values, averaging (116.680).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. GNMLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNMLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.